Discussions around healthcare spending have been ignored for decades, but Robert Dubois, MD, PhD, chief science officer and executive vice president at National Pharmaceutical Council, believes we have the ability to start those discussions now.
Discussions around healthcare spending have been ignored for decades, but Robert Dubois, MD, PhD, chief science officer and executive vice president at National Pharmaceutical Council, believes we have the ability to start those discussions now.
Transcript
In the United States we have typically avoided difficult healthcare spending discussions. How vital are these discussions and why do you believe they can be done?
Well, I think it’s vital that we begin to have a discussion around healthcare spending. We’ve kicked the can down the road for several decades now and problems are getting worse and worse. Whether you look at the percentage of GDP that’s spent on healthcare—if you look at the cost of health premiums—if you look at the impact of premiums on wages, whether states can provide funds for education or road repair. All of these things are crowding out because of what’s going on in the healthcare spending arena. The problem also is that the longer we delay, the more draconian the changes and the interventions are going to need to be. Medicare trust fund is going to expire in the next 6-8 years and the types of changes that are going to be required are going to be really tough if we push this off much further. Now, the next obvious question is can we actually talk about tough issues like healthcare spending—I actually believe we can. We’ve begun a series of town hall dialogues in local communities. We’ve had 1 in Nashville and 1 in Raleigh and we’ve brought local people together to talk about healthcare spending and the issues related to that—and we’ve got 6 more of these queued up. So, I'm actually quite optimistic that we can have the discussion and I’m absolutely convinced that we must have the discussion.
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More